Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since Aug 27 · above the Ichimoku cloud · RSI 48 · MACD below its signal · 9% below its 52-week high
| 8.82 | Previous month high | +10.25% |
| 8.82 | 52-week high | +10.25% |
| 8.40 | Previous week high | +5.00% |
| 8.34 | R3 (classic) | +4.29% |
| 8.27 | R2 (classic) | +3.33% |
| 8.19 | Previous day high | +2.37% |
| 8.13 | R1 (classic) | +1.67% |
| 8.06 | Pivot | +0.71% |
| 8.00 | Price now | |
| 7.98 | Previous day low | −0.25% |
| 7.98 | Previous week low | −0.25% |
| 7.92 | S1 (classic) | −0.96% |
| 7.85 | S2 (classic) | −1.92% |
| 7.71 | S3 (classic) | −3.58% |
| 7.00 | Previous month low | −12.50% |
| 4.78 | 52-week low | −40.25% |
| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| ARK Investment Management · Cathie Wood | $3.1M | 0.02% | 419.78K | −5.5% | Q2 2026 |
| Renaissance Technologies | $2.2M | 0.00% | 296.20K | −2.8% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a MTLS trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for MTLS.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.7 | -6.0 | -4.6 | 11.1 | 21.5 | 11.4 | -14.5 | 13.5 | 18.7 | -6.5 | +44.1% | ||
| 2025 | 19.0 | -37.2 | -6.5 | 4.5 | 4.9 | 4.8 | -8.7 | -1.0 | 9.0 | 14.9 | -5.8 | -8.0 | −21.2% |
| 2024 | -13.7 | -4.8 | -2.2 | -1.1 | -4.2 | 0.2 | 29.7 | -17.7 | 2.4 | 7.8 | 29.1 | -7.7 | +7.2% |
| 2023 | 19.8 | -18.4 | -3.5 | 8.3 | 3.7 | -7.3 | -7.6 | -15.3 | -18.8 | 0.2 | 15.1 | 3.8 | −25.3% |
| 2022 | -14.1 | 0.9 | -6.5 | -19.4 | -6.2 | -6.9 | 3.1 | -16.7 | -8.4 | -1.1 | -8.9 | -8.8 | −63.1% |
| 2021 | 20.4 | -30.3 | -21.0 | -16.8 | -9.8 | -10.7 | -9.6 | 1.3 | -8.9 | 20.0 | 0.9 | -2.0 | −56.0% |
| 2020 | -0.7 | -9.0 | 12.3 | 10.2 | 23.3 | -10.5 | -0.7 | 81.4 | -9.2 | -8.0 | 28.2 | 24.4 | +196.1% |
| 2019 | -17.5 | 16.2 | -18.0 | 5.8 | -11.1 | 31.8 | -0.7 | 1.4 | -6.0 | 3.3 | -7.4 | 3.6 | −8.6% |
| 2018 | 1.0 | -9.5 | 0.6 | 2.6 | 0.8 | 7.5 | -3.0 | 20.3 | -8.9 | 6.9 | -4.5 | 42.3 | +57.6% |
| 2017 | 7.7 | 9.2 | 0.8 | 21.0 | 16.2 | -7.2 | 28.1 | -9.1 | 5.4 | 6.7 | -6.0 | -12.9 | +65.5% |
| 2016 | -13.0 | 0.7 | 23.0 | -3.0 | -3.5 | 0.6 | -3.1 | -10.8 | 24.6 | -11.3 | 18.9 | -5.4 | +8.8% |
| 2015 | -7.9 | -8.4 | -13.0 | 5.7 | 11.2 | 10.7 | -3.7 | -6.1 | -6.6 | 9.8 | -5.6 | -11.4 | −25.8% |
| 2014 | -1.6 | 10.6 | -10.3 | -2.0 | -7.5 | -6.5 | −17.2% |
TimeframesUp on the weekly and monthly, down on the hourly, mixed on the daily.
under a falling 21 EMA, 21 under 50
pulling back under the 21 EMA
over a rising 21 EMA, 21 over 50
over a rising 21 EMA, 21 over 50
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
Buy / hold / sell counts